相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's disease
Yanaika. S. S. Hok-A-Hin et al.
JOURNAL OF NEUROINFLAMMATION (2023)
Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers
Claire Bridel et al.
BRAIN (2022)
Alzheimer's disease clinical trial update 2019-2021
Joseph Pleen et al.
JOURNAL OF NEUROLOGY (2022)
Blood-Based Alzheimer's Biomarkers
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Multi-platform proteomic analysis of Alzheimer's disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome
Eric B. Dammer et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
Multi-Omics Interdisciplinary Research Integration to Accelerate Dementia Biomarker Development (MIRIADE)
Ekaterina Mavrina et al.
FRONTIERS IN NEUROLOGY (2022)
Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid
Yanaika S. Hok-A-Hin et al.
NEUROBIOLOGY OF DISEASE (2022)
CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
Marta del Campo et al.
NATURE AGING (2022)
Alzheimer's disease drug development pipeline: 2022
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Charlotte E. Teunissen et al.
LANCET NEUROLOGY (2022)
Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling
Agnese Petrera et al.
JOURNAL OF PROTEOME RESEARCH (2021)
Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results
M. van de Beek et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery
Bing Bai et al.
MOLECULAR NEURODEGENERATION (2021)
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Jakob M. Bader et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease
Lenora Higginbotham et al.
SCIENCE ADVANCES (2020)
Thimet Oligopeptidase Biochemical and Biological Significances: Past, Present, and Future Directions
Emer S. Ferro et al.
BIOMOLECULES (2020)
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
Daniel Alcolea et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization
Nilton B. dos Santos et al.
BIOMOLECULES (2019)
High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
Stefan Enroth et al.
COMMUNICATIONS BIOLOGY (2019)
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
Daniel Alcolea et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Amsterdam Dementia Cohort: Performing Research to Optimize Care
Wiesje M. van der Flier et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Charlotte E. Teunissen et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results
Betty M. Tijms et al.
CLINICAL CHEMISTRY (2018)
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis
Klementy Shchetynsky et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
Lauren Walker et al.
ACTA NEUROPATHOLOGICA (2015)
A microfluidic multiplex proteomic immunoassay device for translational research
Jing Cao et al.
CLINICAL PROTEOMICS (2015)
A practical guide to immunoassay method validation
Ulf Andreasson et al.
FRONTIERS IN NEUROLOGY (2015)
The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2014)
Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
Wiesje M. van der Flier et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Antibody-based proteomics and biomarker research-Current status and limitations
Corinne Solier et al.
PROTEOMICS (2014)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Biomarkers: hopes and challenges in the path from discovery to clinical practice
Nikolaos G. Frangogiannis
TRANSLATIONAL RESEARCH (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Aβ toxicity
Giuseppe Pollio et al.
NEUROBIOLOGY OF DISEASE (2008)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry
E Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Comparative fine structural distribution of endopeptidase 24.15 (EC3.4.24.15) and 24.16 (EC3.4.24.16) in rat brain
JD Fontenele-Neto et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2001)